658 related articles for article (PubMed ID: 17016559)
41. Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice.
Cheng L; Wang J; Li X; Xing Q; Du P; Su L; Wang S
PLoS One; 2011 Mar; 6(3):e17631. PubMed ID: 21394214
[TBL] [Abstract][Full Text] [Related]
42. Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression.
Garcia AJ; Ruscetti M; Arenzana TL; Tran LM; Bianci-Frias D; Sybert E; Priceman SJ; Wu L; Nelson PS; Smale ST; Wu H
Mol Cell Biol; 2014 Jun; 34(11):2017-28. PubMed ID: 24662052
[TBL] [Abstract][Full Text] [Related]
43. CD45
Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
[TBL] [Abstract][Full Text] [Related]
44. Immunosuppressive CD11b+Ly6Chi monocytes in pristane-induced lupus mouse model.
Ma H; Wan S; Xia CQ
J Leukoc Biol; 2016 Jun; 99(6):1121-9. PubMed ID: 26657791
[TBL] [Abstract][Full Text] [Related]
45. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.
Kemp RA; Ronchese F
J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817
[TBL] [Abstract][Full Text] [Related]
46. Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells.
Narita Y; Wakita D; Ohkur T; Chamoto K; Nishimura T
Biomed Res; 2009 Feb; 30(1):7-15. PubMed ID: 19265258
[TBL] [Abstract][Full Text] [Related]
47. Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer.
Schmidt K; Zilio S; Schmollinger JC; Bronte V; Blankenstein T; Willimsky G
Blood; 2013 Mar; 121(10):1740-8. PubMed ID: 23305737
[TBL] [Abstract][Full Text] [Related]
48. IFN-gamma inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response.
Apte SH; Groves P; Olver S; Baz A; Doolan DL; Kelso A; Kienzle N
J Immunol; 2010 Jul; 185(2):998-1004. PubMed ID: 20562261
[TBL] [Abstract][Full Text] [Related]
49. A Monocyte-Orchestrated IFN-I-to-IL-4 Cytokine Axis Instigates Protumoral Macrophages and Thwarts Poly(I:C) Therapy.
Guo P; Yang L; Zhang M; Zhang Y; Tong Y; Cao Y; Liu J
J Immunol; 2021 Jul; 207(2):408-420. PubMed ID: 34193600
[TBL] [Abstract][Full Text] [Related]
50. Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.
Santodonato L; D'Agostino G; Nisini R; Mariotti S; Monque DM; Spada M; Lattanzi L; Perrone MP; Andreotti M; Belardelli F; Ferrantini M
J Immunol; 2003 May; 170(10):5195-202. PubMed ID: 12734367
[TBL] [Abstract][Full Text] [Related]
51. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
[TBL] [Abstract][Full Text] [Related]
52. Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8(+) CTL avidity.
Ranasinghe C; Ramshaw IA
Eur J Immunol; 2009 Jul; 39(7):1819-30. PubMed ID: 19582753
[TBL] [Abstract][Full Text] [Related]
53. Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα.
Sinha P; Parker KH; Horn L; Ostrand-Rosenberg S
Eur J Immunol; 2012 Aug; 42(8):2052-9. PubMed ID: 22673957
[TBL] [Abstract][Full Text] [Related]
54. Predominant role of interferon-γ in the host protective effect of CD8(+) T cells against Neospora caninum infection.
Correia A; Ferreirinha P; Botelho S; Belinha A; Leitão C; Caramalho Í; Teixeira L; González-Fernandéz Á; Appelberg R; Vilanova M
Sci Rep; 2015 Oct; 5():14913. PubMed ID: 26449650
[TBL] [Abstract][Full Text] [Related]
55. Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host.
Bandyopadhyay S; Bhattacharjee A; Banerjee S; Halder K; Das S; Paul Chowdhury B; Majumdar S
Infect Immun; 2015 Dec; 83(12):4476-86. PubMed ID: 26351281
[TBL] [Abstract][Full Text] [Related]
56. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
[TBL] [Abstract][Full Text] [Related]
57. Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice.
Mundy-Bosse BL; Lesinski GB; Jaime-Ramirez AC; Benninger K; Khan M; Kuppusamy P; Guenterberg K; Kondadasula SV; Chaudhury AR; La Perle KM; Kreiner M; Young G; Guttridge DC; Carson WE
Cancer Res; 2011 Aug; 71(15):5101-10. PubMed ID: 21680779
[TBL] [Abstract][Full Text] [Related]
58. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12.
Zou W; Borvak J; Marches F; Wei S; Galanaud P; Emilie D; Curiel TJ
J Immunol; 2000 Oct; 165(8):4388-96. PubMed ID: 11035076
[TBL] [Abstract][Full Text] [Related]
59. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.
Tähtinen S; Kaikkonen S; Merisalo-Soikkeli M; Grönberg-Vähä-Koskela S; Kanerva A; Parviainen S; Vähä-Koskela M; Hemminki A
PLoS One; 2015; 10(6):e0131242. PubMed ID: 26107883
[TBL] [Abstract][Full Text] [Related]
60. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
